Skip to content

Valcon Pharma

Active Private limited companyfounded 2025active for 1 yearGijsbeekstraat 27, 2811 MechelenKBO/BCE: BE 1020.805.333

Lifetime

1 annual account with figures
peak of €106,762 in 2025
€106,762 
peak of €76,262 in 2025
€76,262 
peak of €81,262 in 2025
€81,262 
€29,403 
Board1 name since 2025
1 director
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Incorporation 11-031 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €200,000 estimated

The micro format states no turnover.

Position in the sector

€76,262

Higher net result than 86% of companies in advertising and market research. Sector median €14,082 · 9,133 companies.

2025 accounts filed 28 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 11,279 companies had the same profile as Valcon Pharma has now. Each dot stands for 29 companies, two years later.

96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 11,279 companies, not a prediction for Valcon Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 07-03-2025
  • founderdeed of 11-03-2025
  • 100 sharesdeed of 11-03-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1020805333
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 11-03-2025 · Gazette deed
First establishment Gijsbeekstraat 27, Mechelen
All 4 events

Comparable companies

same main activity, similar in size and age
Company
Valcon Pharma Mechelen €110,665 €106,762 73.4% -
SiCa-V Dessel €100,984 €97,729 41.4% -
LSCM Rijkevorsel €118,465 €92,405 57.3% -
MILL Antwerp €105,065 €88,414 69.0% -
ImpactEM Advisory Brasschaat €108,962 €103,590 78.6% -
OKALOU Uccle €114,565 €104,239 64.3% -
SC Advisory Schaerbeek €116,951 €101,977 68.9% -

These companies have the same main activity as Valcon Pharma: public relations and communication consultancy (NACE 73300). They are comparable in size and age: total assets between €101,000 and €118,000, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 07-03-2025Normal situation
Activity
Public relations and communication consultancyNACE 73300and 5 others
Establishment unit
2.370.977.8292811 Mechelen, since 07-03-2025
Financial year end
31 December
Peppol
Reachable since 05-10-2025
Company details

Annual accounts 2025

€110,665
Filing
Filed on 28-08-2026
Financials

Insights on Valcon Pharma

Valcon Pharma has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €81,262 and a net result of €76,262.

Its solvency ranks better than 70% of 9,132 sector peers (NACE 73) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Valcon Pharma

What is the company number of Valcon Pharma?
The company number of Valcon Pharma is 1020.805.333. The VAT number is the same number with BE in front: BE 1020.805.333.
Where is Valcon Pharma based?
The registered office is at Gijsbeekstraat 27, 2811 Mechelen.Company details
What does Valcon Pharma do?
According to the KBO register, the main activity is public relations and communication consultancy (NACE 73300).
What is the legal form of Valcon Pharma?
Valcon Pharma is a private limited company (BV).
When was Valcon Pharma founded?
Valcon Pharma was founded on 07-03-2025.
Is Valcon Pharma still active?
Yes, Valcon Pharma is an active enterprise in the KBO register.
What is the turnover of Valcon Pharma?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €106,762 and 38 comparable companies (NACE 73). It probably lies between €150,000 and €390,000.Financials
Is Valcon Pharma profitable?
In financial year 2025, Valcon Pharma made a profit of €76,262.
Where can I find the annual accounts of Valcon Pharma?
Valcon Pharma filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.